Novel metals and metal complexes as platforms for cancer therapy
about
Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical DevelopmentColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerAntibacterial activities of sulfamethoxazolyl-azo-phenols and their Cu(II) complexes along with molecular docking properties.Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumorsUnravelling the correlation between metal induced aggregation and cellular uptake/subcellular localization of Znsalen: an overlooked rule for design of luminescent metal probes.Cisplatin in cancer therapy: molecular mechanisms of actionTargeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cellsDifferent apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary cultureAuranofin, an anti-rheumatic gold compound, modulates apoptosis by elevating the intracellular calcium concentration ([ca2+]I) in mcf-7 breast cancer cells.Solid-phase synthesis as a platform for the discovery of new ruthenium complexes for efficient release of photocaged ligands with visible light.Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.Synthesis, characterization, thermal properties and antiproliferative potential of copper(II) 4'-phenyl-terpyridine compounds.Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity.Selective Release of Aromatic Heterocycles from Ruthenium Tris(2-pyridylmethyl)amine with Visible LightLow Doses of Cisplatin Induce Gene Alterations, Cell Cycle Arrest, and Apoptosis in Human Promyelocytic Leukemia CellsAntagonizing STAT5B dimerization with an osmium complex.MALDI-TOFMS analysis of coordination and organometallic complexes: a nic(h)e area to work in.Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs.The many "faces" of copper in medicine and treatment.Metal complexes in cancer therapy - an update from drug design perspective.Ruthenium-based nitric oxide-donating and carbon monoxide-donating molecules.Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells.Clotrimazole as a Cancer Drug: A Short Review.Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.Sugar-boronate ester scaffold tethered pyridyl-imine palladium(II) complexes: synthesis and their in vitro anticancer evaluation.Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures.Potent inhibition of protein tyrosine phosphatases by quinquedentate binuclear copper complexes: synthesis, characterization and biological activities.New perspectives of cobalt tris(bipyridine) system: anti-cancer effect and its collateral sensitivity towards multidrug-resistant (MDR) cancers.Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts in vivo by an enantiomeric iridium(iii) metal-based compound.Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells.Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia.Heteroleptic Copper(I) Complexes of "Scorpionate" Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode.Cisplatin-Induced Nephrotoxicity; Protective Supplements and Gender DifferencesCisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effectsTherapeutic potential of the phosphino Cu(I) complex (HydroCuP) in the treatment of solid tumors.Selective formation of discrete versus polymeric copper organophosphates: DNA cleavage and cytotoxic activity.Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents.Cobalt complexes with pyrazole ligands as catalyst precursors for the peroxidative oxidation of cyclohexane: X-ray absorption spectroscopy studies and biological applications.Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
P2860
Q28551246-9B48084F-78DE-41B8-A09D-93996D5AA7A9Q30238915-088274DA-E8F6-46A6-A82A-35D40C341249Q30401503-CCCE1D4D-35DF-4C7D-9F59-254B93454113Q33553649-61394B3D-A472-46A0-9EC6-38215E1618DCQ33845822-EEF7C8C2-F4CF-4F73-A403-18C38FDCF82FQ34098163-A23BED27-488D-4535-9F92-7F111D11B02FQ34195083-A56C1373-55C8-4DA8-89DC-8B16DE0FA00DQ34373124-4489682A-0F1A-45D6-A5D0-00E0AF3C4543Q34619471-3F166F13-D2B4-46FE-9264-D11CA0D2AB26Q34774888-45A5C81E-BC6C-4D4F-BB4A-68D8853E6220Q35547191-15CCF131-1C69-46C9-88F9-7063F83F6F65Q35895492-3A1FD710-2293-4D79-80EB-C451DBF1BF59Q35932046-F3C3740E-7D78-46F2-9EF9-2F5F3F78B903Q36102019-F7392146-FB2E-4494-8268-0CDC3DF16D17Q36892716-274014C7-906C-414F-AB49-B2AD9DCBE28EQ37204356-E47EF4C6-6BA9-422D-82F6-CA0157555747Q37419916-B3A9E35F-A1DB-4AAA-B7FB-20D62FEF41CCQ37899834-866F1B26-6983-4FEE-8A2B-2B4B11C6C42FQ38011996-515F41F2-5571-4971-BE83-BB82FA75A4A3Q38205742-6AAE8F61-0720-4A44-B896-386103BAD9A2Q38692975-C63A01A1-F6F7-44B1-8454-26330DF099BCQ38698568-CA264DF0-5F04-452E-827C-DCB13B4FB379Q38701263-7D886A38-EABE-4E34-ADB3-4C98592CEF8BQ38714666-B785E880-2407-419B-BA7F-B096084DD844Q38771349-E9E750A1-5221-46BB-8E75-44B096B5B085Q38833511-2CE5282B-1B0C-4C2D-AA2A-60103C235AF0Q39226440-01F8CE1D-AAA8-4C3C-8BF6-B7F851617D85Q39452671-65171761-89EB-4388-80BA-1DA1A1033553Q41549887-8117676A-F6AF-47BC-8888-49575BC6ED88Q41671042-FF74D74F-B8F7-47F1-9C09-F14ECCFD64ABQ41775376-89652A3D-0A8C-4101-8491-AF5FD978891CQ42029615-C8989AC8-6E94-46FE-9BFF-D624C51B8573Q42130456-0BF0EC3A-1DED-4B2F-87E4-6D9958787475Q42343539-D1D46F1A-962B-4DFC-AEE9-258C3F6BA024Q42575787-A4CF754B-4FC9-4916-B89B-024053AF65F2Q42635176-3ACC50A7-9F71-43CD-948E-40760784CB24Q42693147-5A47D631-EB3E-468F-B098-B47912156072Q46157208-3E4D524A-9605-4C88-AB18-A746CFDAAB51Q46938322-27CBDF57-937A-491F-A98A-3124376EE480Q47446573-9BF19EC9-333D-4094-B9C6-E2D6A2A58A90
P2860
Novel metals and metal complexes as platforms for cancer therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel metals and metal complexes as platforms for cancer therapy
@en
Novel metals and metal complexes as platforms for cancer therapy.
@nl
type
label
Novel metals and metal complexes as platforms for cancer therapy
@en
Novel metals and metal complexes as platforms for cancer therapy.
@nl
prefLabel
Novel metals and metal complexes as platforms for cancer therapy
@en
Novel metals and metal complexes as platforms for cancer therapy.
@nl
P2093
P2860
P1476
Novel metals and metal complexes as platforms for cancer therapy
@en
P2093
Andrew Davenport
Dajena Tomco
Michael Frezza
Q Ping Dou
Sara Schmitt
Sarmad Hindo
P2860
P304
P356
10.2174/138161210791209009
P577
2010-06-01T00:00:00Z